portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Shanghai Pharmaceuticals Invests CNY2 Billion To Deploy Nationwide Network
 
CreateTime:2011-08-22 Editor:hangmei
Text Size:       
 

July 28, 2011 ,Shanghai Pharmaceuticals Holding Company Ltd (601607.SH) has announced that it will make additional investments in its wholly-owned subsidiary, Shanghai Pharmaceutical Distribution Company Ltd.; and it will establish two new wholly-owned subsidiaries to create a nationwide pharmaceutical distribution network.

The company will reportedly invest CNY1.02 billion in cash in Shanghai Pharmaceutical Distribution. Meanwhile, it will establish two new subsidiaries — Shanghai Pharmaceutical North Investment Company and Shanghai Pharmaceutical Information Technology Company — to build its nationwide pharmaceutical distribution network.

Shanghai Pharmaceuticals will invest USD80 million to set up the foreign-invested Shanghai Pharmaceutical North Investment Company via its newly acquired wholly-owned subsidiary, China Health System Ltd. In addition, Shanghai Pharmaceuticals will invest CNY500 million to set up another wholly-owned subsidiary Shanghai Pharmaceutical Information Technology Company to realize the information construction of the group.

On May 20, 2011, Shanghai Pharmaceuticals successfully listed in Hong Kong and gained over USD2 billion through its IPO. According to the prospectus of the company, about 40% of the financed capital will be used to enlarge and enhance its distribution network and integrate its existing distribution network in China.

Shanghai Pharmaceuticals Holding Company Ltd is principally engaged in the manufacture and distribution of pharmaceuticals. The company operates its businesses primarily through the research, development and manufacture of pharmaceuticals, which offers Chinese medicines, chemical drugs, biological products, biochemical drugs and other healthcare products; pharmaceuticals distribution and supply chain solutions, which provides distribution, logistics, warehousing and other pharmaceutical supply chain value-added solutions and related services, as well as pharmaceutical retailing business, which involves in operation and management of regular chain drugstores.

 


Related Reports
China Medical Robot Industry Report, 2020-2026
China Heparin Industry Report, 2015-2018
Global and China Stem Cell Industry Report, 2015-2018
China Medical Robot Industry Report, 2014-2018
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1